Streetbeat News

Stock Prices

JILL

J. Jill, Inc. reported a Q2 2023 sales decline of 2.9% YoY to $155.7 million, missing the consensus of $152.4 million. Total company comparable sales decreased by 1.3% and direct-to-consumer net sales were down 5.1%. Adjusted EPS was $1.10, beating the consensus of 80 cents. The company expects Q3 revenues to be down in the low single digits YoY, with an adjusted EBITDA of $23 million-$25 million. Despite the sales decline, JILL shares are trading higher by 4.74% to $24.52.

Portfolio Pulse from Akanksha Bakshi

August 31, 2023 | 3:04 pm

CGC

CURLF

TLRY

Shares of Curaleaf Holdings, Inc. (OTC:CURLF) are trading higher after the U.S. Department of Health and Human Services (HHS) recommended the rescheduling of marijuana. Other cannabis sector stocks, including Canopy Growth Corporation (NASDAQ:CGC) and Tilray Brands, Inc. (NASDAQ:TLRY), are also soaring on the news.

Portfolio Pulse from Erica Kollmann

August 31, 2023 | 3:04 pm

DLTH

Duluth Holdings Inc. (NASDAQ:DLTH) reported a Q2 FY23 sales decline of 1.7% YoY to $139.10 million, beating the consensus of $138.41 million. However, the EPS loss of $(0.06) missed the analyst consensus of breakeven $(0.00). Retail store net sales decreased by 7% due to slower store traffic. The company's CFO, Dave Loretta, will step down effective September 15. Duluth reaffirmed its FY23 revenue outlook of $645 million-$660 million. DLTH shares are trading lower by 13% at $6.39.

Portfolio Pulse from Nabaparna Bhattacharya

August 31, 2023 | 3:03 pm

CGC

Canopy Growth Corporation (NASDAQ:CGC) shares are trading higher after the U.S. Department of Health and Human Services (HHS) recommended the rescheduling of marijuana. The recommendation is for marijuana to be rescheduled to a Schedule III substance from its current Schedule I status. The news has resulted in heavy trading volume for CGC shares, with over 30.7 million shares traded in the session, compared to the stock's 100-day average of 26.803 million shares.

Portfolio Pulse from Erica Kollmann

August 31, 2023 | 3:01 pm

MCFT

Over the past 3 months, 5 analysts have published their opinion on MasterCraft Boat Hldgs (NASDAQ:MCFT) stock. The company has an average price target of $27.8, representing a 29.17% decrease from the previous average price target of $39.25. The analysts' ratings range from bullish to indifferent.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 3:00 pm

VRA

Over the past 3 months, 4 analysts have published their opinion on Vera Bradley (NASDAQ:VRA) stock. The majority of these ratings are bullish, with an average price target of $9.25, an increase of 8.82% from the previous average price target of $8.50.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 3:00 pm

ARGX

In the last quarter, 20 analysts have provided ratings for argenx (NASDAQ:ARGX), with 11 being bullish, 7 somewhat bullish, and 2 indifferent. The company has an average 12-month price target of $546.9, which has increased by 6.87% over the past month.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 3:00 pm

DBX

Dropbox (NASDAQ:DBX) has received mixed analyst ratings in the last quarter, with 5 somewhat bullish, 3 indifferent, and 1 somewhat bearish. The average price target is $30.0, indicating an upside from the current price of $27.925. The average price target has increased by 12.7% over the past month.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 3:00 pm

EW

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 10.03% on an annualized basis, producing an average annual return of 20.59%. If an investor had bought $1000 of EW stock 10 years ago, it would be worth $6,579.08 today.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 3:00 pm

NVS

Novartis's (NYSE:NVS) short percent of float has risen 5.26% since its last report, with 3.89 million shares sold short, which is 0.2% of all regular shares available for trading. It would take traders 3.77 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Novartis's peer group average for short interest as a percentage of float is 4.55%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 3:00 pm